Double Crane Biotechnology Co. Ltd.

Kuang-Dee Chen

Chih-Wei Chen

Teng-Hai Chen

Cheng-Po Huang

Li-Ming Huang

Mon-Tarng Chen

Yen-Chun Liu

Shwu-Bin Lin

Yan-Chun Liu

Disclosed herein is an industrial scale process of cultivating cultivatingmycelia. As high as 15 Kg driedmycelia may be produced from about 300 liters liquid culture every 30 days, and the resulting driedmycelia are rich in triterpenoids that include at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS).

[object Object]

Disclosed herein is a composition that includes a novel combination of triterpenoids for the treatment or prophylaxis of a cancer. The triterpenoids includes at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS). The composition is suitable for the treatment or prophylaxis of colon cancer, hepatic cancer, breast cancer, lung cancer or leukemia.

Therapeutic composition for treating cancers

Growing community of inventors

Chiayi, Taiwan

Kuang-Dee Chen